Alnylam Pharmaceuticals
ALNY
#860
Rank
ยฃ21.97 B
Marketcap
ยฃ164.20
Share price
1.09%
Change (1 day)
-49.25%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company